Newsworthy Notes: What We’ve Been Up To in 2022
It’s hard to believe that the first half of the year is almost over! The NATF Board of Directors, Medical Advisory Board (MAB), and staff are pleased to share some exciting developments that have taken place since January.
We’ve filled all open seats on our Board of Directors
Meet Jelena Spyropoulos, NATF’s Chair of Corporate Partnerships!
Jelena will help NATF identify new opportunities and build relationships with industry sponsors, foundations, and other potential funders.
Jelena obtained her PhD in Molecular Genetics at the Albert Einstein College of Medicine in New York City and has more than 15 years of experience in the medical education industry. Jelena began her career as a medical writer, focusing on scientific publications in the areas of cancer, anticoagulation, and heart disease. She has since overseen scientific communications for several areas of medicine while maintaining a focus in anticoagulation management. Jelena currently works at Medscape Education Global and leads the team responsible for new business development.
We hired a summer intern
NATF is thrilled to welcome Trinie Tang to our team for the summer. Trinie is a 5th-year pharmacy student at the Massachusetts College of Pharmacy and Health Sciences and is also an Inpatient Pharmacy Intern at Brigham and Women’s Hospital. During her time at NATF, she’ll be helping us revamp several of our key patient resources on anticoagulation. We’re excited to have her on board!
We had our first in-person meeting in more than two years
In April, the NATF staff, Board of Directors, and MAB came together in person for the first time since the pandemic began. We spent two productive days together discussing strategic plans and educational priorities for the next 3-10 years. It was wonderful to collaborate and brainstorm face to face!